| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $564.2M | +6.9% |
| Cost of Revenue | $442.7M | +6.0% |
| R&D Expense | $500K | +0.0% |
| SG&A Expense | $92.0M | -3.2% |
| Operating Income | $3.6M | +123.4% |
| Interest Expense | $18.9M | +2.0% |
| Pre-tax Income | -$12.8M | +60.3% |
| Income Tax | $3.4M | +245.6% |
| Net Income | -$17.4M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.1M | +66.4% |
| Accounts Receivable | $36.7M | +42.9% |
| Inventory | $18.2M | -33.3% |
| Current Assets | $187.7M | +14.7% |
| Total Assets | $558.5M | +3.0% |
| Current Liabilities | $118.0M | +15.8% |
| Long-term Debt | $143.2M | +7.6% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.8M | +6921.7% |
| Capital Expenditures | $12.7M | -21.6% |
| Investing Cash Flow | -$16.4M | +0.3% |
| Financing Cash Flow | -$7.1M | +62.8% |
| Free Cash Flow | $16.1M | +202.4% |
| +50.3% |
| EPS (Basic) | -$0.27 | +51.8% |
| EPS (Diluted) | -$0.27 | +51.8% |
| Total Liabilities |
| $303.2M |
| +7.0% |
| Stockholders' Equity | $175.9M | -2.0% |